Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.390
-0.020 (-0.59%)
Apr 17, 2026, 4:00 PM EDT - Market closed

MRVI Revenue

In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. Maravai LifeSciences Holdings had revenue of $49.87M in the quarter ending December 31, 2025, a decrease of -11.83%.

Revenue (ttm)
$185.74M
Revenue Growth
-28.34%
P/S Ratio
4.69
Revenue / Employee
$426,995
Employees
435
Market Cap
871.46M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MannKind348.97M
Xencor125.58M
Theravance Biopharma107.46M
Arbutus Biopharma14.08M
Janux Therapeutics10.00M
Revenue Rankings